Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2016-08-09 Tx date 2016-08-04 |
$VVS
Avapecia Life Sciences Corp. |
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$200.00
+4,000 vol $0.05 each |
2,553,250 | |
Filed 2016-01-25 Tx date 2016-01-15 |
$VVS
Avapecia Life Sciences Corp. |
Tsui, Norman
4 - Director of Issuer
Holder: Norman Tsui ITF Brianna Tsui (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
860,000 | ||
Filed 2016-01-25 Tx date 2016-01-15 |
$VVS
Avapecia Life Sciences Corp. |
Tsui, Norman
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
11,640,000 | ||
Filed 2016-01-25 Tx date 2016-01-15 |
$VVS
Avapecia Life Sciences Corp. |
Tsui, Norman
4 - Director of Issuer
Holder: Norman Tsui ITF Ethan Tsui (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
860,000 | ||
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+67,500 vol |
67,500 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+652,500 vol |
2,152,500 | |
Filed 2016-01-05 Tx date 2014-05-16 |
$VVS
Avapecia Life Sciences Corp. |
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Holder: Cytostream Life Sciences Inc. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Holder: Cytostream Life Sciences Inc. (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+72,000 vol |
72,000 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Lynnett Darrell (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+22,500 vol |
86,500 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Lynnett Darrell (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+22,500 vol |
109,000 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Neweduk, Peter Micheal
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+533,250 vol |
2,549,250 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Cyto IQ Biomedical Corp. (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+9,947,543 vol |
25,847,543 | |
Filed 2016-01-05 Tx date 2014-05-30 |
$VVS
Avapecia Life Sciences Corp. |
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Dawn Tam (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Holder: Dawn Tam (Control or Direction)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+720,000 vol |
720,000 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Tam, Alan Shui Yan
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+3,074,999 vol |
5,324,999 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Nerland, Dennis Leroy
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+686,250 vol |
1,786,250 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
CHANG, MICHELE KAR MAN
4 - Director of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+45,000 vol |
182,000 | |
Filed 2016-01-05 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
CHANG, MICHELE KAR MAN
4 - Director of Issuer
Holder: Tony H.Y. Leung (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+45,000 vol |
182,000 | |
Filed 2016-01-05 Tx date 2014-11-10 |
$VVS
Avapecia Life Sciences Corp. |
Chiu, Szu Min (Jasmine)
4 - Director of Issuer
Holder: Percy Gar Kay Cheung (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-01-04 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+616,500 vol |
1,116,500 | |
Filed 2016-01-04 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Huang, Lotien Richard
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+18,407,545 vol |
39,107,545 | |
Filed 2016-01-04 Tx date 2015-12-21 |
$VVS
Avapecia Life Sciences Corp. |
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Fuller Family Trust (Indirect Ownership)
|
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
+247,500 vol |
247,500 | |
Filed 2016-01-04 Tx date 2014-01-10 |
$VVS
Avapecia Life Sciences Corp. |
Fuller, Jason Peter
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Fuller Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|